Vectura

July 7, 2017July 7, 2017

Vectura Signs Agreement with Sandoz to Develop Generic Combination Therapy for Asthma and COPD in the U.S.

News

A generic version of an existing inhaled combination therapy for asthma and chronic obstructive pulmonary disease (COPD) will be developed in the United States under an agreement between Vectura Group subsidiary Jagotec ... Read more

January 7, 2015November 11, 2015

Vectura and Janssen Enter Global Partnership for Asthma, COPD

Asthma, COPD, News

Vectura Group, a product development company that specializes in pharmaceutical therapies for airway-related diseases, has just announced it has signed an international development and licensing agreement with Janssen Biotech, Inc., a ... Read more

August 21, 2014November 6, 2015

Novel Vectura Asthma Monotherapy Now in Full Development

Asthma, News

Investors on Wall Street have responded positively to a recent US collaboration, development, and license agreement established by the Vectura Group, a respiratory product development company, for the development of its clinical ... Read more